This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

No content found

Sunday, February 25 | 4:00PM - 8:00PM
Arrival and Registration
Room: Grand Foyer


Sunday, February 25 | 6:00PM - 8:00PM
Welcome Mixer
Room: Grand Foyer
No registration fees are used to fund alcohol served at this function.

Monday, February 26 | 7:00AM - 8:00AM
Breakfast
Room: Sea to Sky C


Monday, February 26 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Sea to Sky B

Speaker 1 of 4
* Paul W. H. I. Parren, Leiden University Medical Center, Netherlands

Monday, February 26 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Sea to Sky B

Speaker 2 of 4
* Erica Ollmann Saphire, La Jolla Institute for Immunology, USA

Monday, February 26 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Sea to Sky B

Speaker 3 of 4
* David I. Watkins, University of Miami, USA

Monday, February 26 | 8:00AM - 9:00AM
Welcome and Keynote Address
Room: Sea to Sky B

Speaker 4 of 4
Dennis R. Burton, The Scripps Research Institute, USA
Molecular Vaccine Design Guided by Human Anti-Viral Antibodies

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B

Speaker 1 of 7
* David I. Watkins, University of Miami, USA

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B

Speaker 2 of 7
George Georgiou, University of Texas at Austin, USA
The Human Serological and BCR Antibody Repertoires in Cancer, Autoimmunity or following Vaccination

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B


Coffee Break

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B

Speaker 4 of 7
Erica Ollmann Saphire, La Jolla Institute for Immunology, USA
Systematic Analysis of Monoclonal Antibodies Against Ebola Virus GP Defines Features that Contribute to Protection

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B

Speaker 5 of 7
Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Lessons from the Analysis of the Immune Response to P. falciparum

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B

Speaker 6 of 7
Arthur S. Kim, Washington University School of Medicine, USA
Short Talk: Identification of Protective Antibody Epitopes on the Eastern Equine Encephalitis Virus Envelope Protein

Monday, February 26 | 9:00AM - 11:30AM
Protective Antibody Responses
Room: Sea to Sky B

Speaker 7 of 7
Sarah Elliott, Wistar Institute, USA
Short Talk: DNA-Encoded Monoclonal Antibody (DMAb) for Acute Prophylaxis Against Influenza

Monday, February 26 | 11:30AM - 1:00PM
Poster Setup


Monday, February 26 | 1:00PM - 10:00PM
Poster Viewing
Room: Grand Foyer


Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 1 of 9
* Ann J. Hessell, Oregon Health & Science University, USA

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 2 of 9
Tongqing Zhou, NIAID, National Institutes of Health, USA
Structural Basis of Zika-Neutralizing Monoclonal Antibodies Elicited in Immunized Macaque Monkeys

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 3 of 9
Brett W. Jagger, Washington University, USA
Efficacy of Zika Virus Vaccines Against Zika Infection in Mice During Pregnancy

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 4 of 9
Laura A. Powell, Vanderbilt University, USA
Cross-Reactive and Potently Neutralizing Antibody Response in a Donor Naturally Infected with Ross River Virus

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 5 of 9
Natasha D. Durham, Tufts University, USA
Neutralizing Antibodies Remodel the Conformational Landscape of Ebola GP

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 6 of 9
Hideki Hasegawa, National Institute of Infectious Diseases, Japan
Enhancement of Anti-Viral Effects of an Intranasal Inactivated Influenza Vaccine-Derived Broadly Neutralizing Antibody by IgA Polymerization

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 7 of 9
Bryan Briney, The Scripps Research Institute, USA
Exceptionally Deep Antibody Repertoire Sequencing to Guide mAb Discovery and Development

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 8 of 9
Ron Diskin, Weizmann Institute of Science, Israel
Targeting TfR1-Tropic Arenaviruses at their Achilles Heel: Structure-Based Rational Design of Universal Immunotherapy

Monday, February 26 | 2:30PM - 4:30PM
Workshop 1: Antibodies and Protection
Room: Sea to Sky B

Speaker 9 of 9
Matthijs M. Jore, Radboud University Medical Center, Netherlands
Engineered Antibodies Against Plasmodium Transmission from Man to Mosquito

Monday, February 26 | 4:30PM - 5:00PM
Coffee Available
Room: Grand Foyer


Monday, February 26 | 5:00PM - 7:00PM
From Molecules to Vaccines
Room: Sea to Sky B

Speaker 1 of 5
* Erica Ollmann Saphire, La Jolla Institute for Immunology, USA

Monday, February 26 | 5:00PM - 7:00PM
From Molecules to Vaccines
Room: Sea to Sky B

Speaker 2 of 5
Nancy L. Haigwood, Oregon Health & Science University, USA
Antibody-Based HIV Therapeutics: 'Hit Early, Hit Hard'

Monday, February 26 | 5:00PM - 7:00PM
From Molecules to Vaccines
Room: Sea to Sky B

Speaker 3 of 5
James E. Crowe, Jr., Vanderbilt University Medical Center, USA
Genetic and Structural Basis for Virus Neutralization by Human Antibodies

Monday, February 26 | 5:00PM - 7:00PM
From Molecules to Vaccines
Room: Sea to Sky B

Speaker 4 of 5
Robert F. Garry, Tulane University Health Sciences Center, USA
Antibody Treatment of Lassa Virus: From the Field to the Lab and Back

Monday, February 26 | 5:00PM - 7:00PM
From Molecules to Vaccines
Room: Sea to Sky B

Speaker 5 of 5
Ruoke Wang, Tsinghua University, China
Short Talk: Delineating Antibody Recognition Against Envelope Protein of Zika Virus during Natural Infection

Monday, February 26 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Sea to Sky C
No registration fees are used to fund alcohol served at this function.

Monday, February 26 | 7:30PM - 10:00PM
Poster Session 1
Room: Grand Foyer


Tuesday, February 27 | 7:00AM - 8:00AM
Breakfast
Room: Sea to Sky C


Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 1 of 8
Janine Schuurman, Genmab B.V., Netherlands
Therapeutic Antibody Panorama: Highways, Scenic Routes and Dead-Ends



Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 2 of 8
Karl Dane Wittrup, Massachusetts Institute of Technology, USA
Principles of Effective Antibody Therapeutics

Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B


Coffee Break

Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 4 of 8
Marie H. Kosco-Vilbois, AC Immune, Switzerland
Creating Molecules that Succeed in the Clinic

Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 5 of 8
Emma M. Lees, Bristol Myers Squibb, USA
JTX-2011: Mechanism of Action of an Agonist Antibody Targeting ICOS

Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 6 of 8
* Ira Mellman, Genentech, Inc., USA
Antibodies in Cancer Immunotherapy

Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 7 of 8
Cory Brooks, California State University, Fresno, USA
Short Talk: Glycosylation of MUC1 Influences the Binding of a Therapeutic Antibody by Altering the Conformational Equilibrium of the Antigen

Tuesday, February 27 | 8:00AM - 11:45AM
Antibodies as Biopharmaceuticals
Room: Sea to Sky B

Speaker 8 of 8
Alexander W. Koch, Novartis Institutes for BioMedical Research, USA
Short Talk: Targeting Coagulation Factor XI (FXI) for Thrombosis Prevention

Tuesday, February 27 | 11:45AM - 5:00PM
On Own for Lunch


Tuesday, February 27 | 11:45AM - 1:00PM
Poster Setup
Room: Grand Foyer


Tuesday, February 27 | 1:00PM - 10:00PM
Poster Viewing
Room: Grand Foyer


Tuesday, February 27 | 4:30PM - 5:00PM
Coffee Available
Room: Grand Foyer


Tuesday, February 27 | 5:00PM - 7:15PM
Antibody Fc-Mediated Mechanisms I
Room: Sea to Sky B

Speaker 1 of 6
* Pierre Bruhns, Institut Pasteur, France

Tuesday, February 27 | 5:00PM - 7:15PM
Antibody Fc-Mediated Mechanisms I
Room: Sea to Sky B

Speaker 2 of 6
Pamela J. Bjorkman, California Institute of Technology, USA
Structural Studies of Antibody and Receptor Binding to HIV-1 Env

Tuesday, February 27 | 5:00PM - 7:15PM
Antibody Fc-Mediated Mechanisms I
Room: Sea to Sky B

Speaker 3 of 6
Jan Terje Andersen, Oslo University Hospital, Norway
HERA: A Human Endothelial Cell-Based Recycling Assay for Screening of FcRn Targeted Molecules

Tuesday, February 27 | 5:00PM - 7:15PM
Antibody Fc-Mediated Mechanisms I
Room: Sea to Sky B

Speaker 4 of 6
Jeffrey S. Miller, University of Minnesota, USA
Strategies to Use Trispecific Killer Engagers to Make NK Cells Antigen Specific


Tuesday, February 27 | 5:00PM - 7:15PM
Antibody Fc-Mediated Mechanisms I
Room: Sea to Sky B

Speaker 5 of 6
Julie M. Fox, Washington University, USA
Short Talk: Antibody Therapy Reduces Chikungunya Virus Disease through an FcgR-Dependent Mechanism

Tuesday, February 27 | 5:00PM - 7:15PM
Antibody Fc-Mediated Mechanisms I
Room: Sea to Sky B

Speaker 6 of 6
James A. Ernst, Genentech, Inc., USA
Short Talk: Optimizing Antibodies for Targeting the Tau Protein for Alzheimer's Disease and Other Tauopathies

Tuesday, February 27 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Sea to Sky C
No registration fees are used to fund alcohol served at this function.

Tuesday, February 27 | 7:30PM - 10:00PM
Poster Session 2
Room: Grand Foyer


Wednesday, February 28 | 7:00AM - 8:00AM
Breakfast
Room: Sea to Sky C


Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 1 of 8
* Marjolein van Egmond, VU University Medical Center, Netherlands

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 2 of 8
Paul W. H. I. Parren, Leiden University Medical Center, Netherlands
Complement Activation at the Molecular Level

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 3 of 8
Suzan Huberdina Maria Rooijakkers, University Medical Center Utrecht, Netherlands
EMBO Young Investigator Lecture: Antibody-Mediated Killing of Bacteria by Complement

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B


Coffee Break

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 5 of 8
Galit Alter, MIT and Harvard University, USA
Correlate Guided Approaches to Develop Antibodies Against Ebola Virus Infection

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 6 of 8
Pierre Bruhns, Institut Pasteur, France
Analyses of Single Ab-Secreting Cells using Droplet Microfluidics

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 7 of 8
David P. Humphreys, UCB Pharma, UK
Short Talk: On Target Hexamerisation of IgG1 Driven by a Mutant form of IgM Tail-Piece C-Terminal Fusion

Wednesday, February 28 | 8:00AM - 11:15AM
Antibody Fc-Mediated Mechanisms II
Room: Sea to Sky B

Speaker 8 of 8
Dieke J. van Rees, Sanquin Research and Landsteiner Laboratory, Netherlands
Short Talk: Sodium Stibogluconate in Conjunction with CD47-SIRP Checkpoint Blockade Enables Rituximab-Mediated Killing of B Lymphoma Cells by Neutrophils

Wednesday, February 28 | 11:15AM - 5:00PM
On Own for Lunch


Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 1 of 9
* Ida Hiemstra, Genmab, Netherlands

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 2 of 9
* Devin Sok, International AIDS Vaccine Initiative, USA
Non-Human Primate Pharmacokinetics of HIV Broadly Neutralizing Antibodies Isolated from Cow Immunizations

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 3 of 9
Amarendra Pegu, NIAID, National Institutes of Health, USA
Trispecific Antibodies Mediate Highly Potent and Broad Neutralization of HIV and Confer Expanded Protection Against SHIV Infection in Macaques

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 4 of 9
Sanjay Ram, University of Massachusetts, USA
Potentiation of Efficacy of a Candidate Immunotherapeutic Anti-Neisseria Gonorrhoeae Antibody by Enhancing IgG Fc Hexamer Formation

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 5 of 9
Nina G. Caculitan, Genentech, Inc., USA
Discovery of the Determinants of Antibody-Drug Conjugate Efficacy and a Novel Resistance Mechanism to Anti-HER2 Therapeutics

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 6 of 9
Jordana Griffiths, University of Southampton, UK
Targeting OX40 in Cancer Immunotherapy

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 7 of 9
John Engelhardt, Bristol-Myers Squibb Company, USA
Next Generation Anti-CTLA-4 Antibodies

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 8 of 9
Ezio Bonvini, MacroGenics, Inc, USA
Tailoring Cytolytic Activity, Proliferation and Cytokine Release via CD3 Engineering of DART® Molecules for Redirected T-cell Killing

Wednesday, February 28 | 2:30PM - 4:30PM
Workshop 2: Therapeutic Antibodies
Room: Sea to Sky B
- Structural aspects of antibodies, novel insights
- Novel therapeutic antibody formats
- Novel antibody technologies
- From target to therapy
- Newly approved and upcoming antibody therapeutics
Speaker 9 of 9
Michael Johnston, Queen's University Belfast, UK
Development of AMG 655 Conjugated Polymeric Nanoparticles Targeting Death Receptor 5 for the Treatment of Pancreatic Cancer

Wednesday, February 28 | 4:30PM - 5:00PM
Coffee Available
Room: Grand Foyer


Wednesday, February 28 | 5:00PM - 7:00PM
Exploiting Effector Cell Responses
Room: Sea to Sky B

Speaker 1 of 5
* Pamela J. Bjorkman, California Institute of Technology, USA

Wednesday, February 28 | 5:00PM - 7:00PM
Exploiting Effector Cell Responses
Room: Sea to Sky B

Speaker 2 of 5
Sergio A. Quezada, University College London, UK
Regulatory T Cells, Polymorphisms and Response to Checkpoint Blockade: From Mechanisms to Potential Biomarkers

Wednesday, February 28 | 5:00PM - 7:00PM
Exploiting Effector Cell Responses
Room: Sea to Sky B

Speaker 3 of 5
Bertrand Routy, Centre hospitalier de l’Université de Montréal, Canada
The Gut Microbiota as a Novel Predictor of Immune Checkpoint Inhibitors Response?

Wednesday, February 28 | 5:00PM - 7:00PM
Exploiting Effector Cell Responses
Room: Sea to Sky B

Speaker 4 of 5
Marjolein van Egmond, VU University Medical Center, Netherlands
Translating Antibody–Effector Cell Cross-Talk to Immunotherapy

Wednesday, February 28 | 5:00PM - 7:00PM
Exploiting Effector Cell Responses
Room: Sea to Sky B

Speaker 5 of 5
Maria Mar Naranjo, Centre National de la Recherche Scientifique, France
Short Talk: Key Immunomodulatory Role of Neutrophils in the Induction of Protective Immunity by Antiviral Monoclonal Antibodies

Wednesday, February 28 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Sea to Sky C
No registration fees are used to fund alcohol served at this function.

Thursday, March 01 | 7:00AM - 8:00AM
Breakfast
Room: Sea to Sky C


Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 1 of 8
* Janine Schuurman, Genmab B.V., Netherlands

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 2 of 8
Ugur Sahin, BioNTech AG, Germany
Antibody and mRNA-Based Therapeutics

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 3 of 8
Mark Cobbold, AstraZeneca, USA
Retargeting T Cells for Tumor Therapy

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B


Coffee Break

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 5 of 8
Markus Schmid, University of Zurich, Switzerland
Paracrine Delivery of Therapeutic Proteins

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 6 of 8
Johannes Lutz, Curevac AG, Germany
mRNA-Encoded Antibodies for Passive Immunization

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 7 of 8
Kalie Mix, Sanofi, USA
Short Talk: Cytosolic Delivery of Antibodies

Thursday, March 01 | 8:00AM - 11:15AM
Novel Ways to Deliver Antibody Therapy
Room: Sea to Sky B

Speaker 8 of 8
Jeffrey J. Bunker, University of Chicago, USA
Short Talk: Natural Polyreactive IgA Antibodies Coat the Intestinal Microbiota

Thursday, March 01 | 11:15AM - 5:00PM
On Own for Lunch


Thursday, March 01 | 4:30PM - 5:00PM
Coffee Available
Room: Grand Foyer


Thursday, March 01 | 5:00PM - 6:45PM
From Molecules to the Clinic
Room: Sea to Sky B

Speaker 1 of 3
* Paul W. H. I. Parren, Leiden University Medical Center, Netherlands

Thursday, March 01 | 5:00PM - 6:45PM
From Molecules to the Clinic
Room: Sea to Sky B

Speaker 2 of 3
David E. Szymkowski, Szymkowski David, USA
Exploring Novel Mechanisms of Action and Clinical Outcomes of Therapeutic Antibodies Fc-Engineered to Optimally Engage Fc Gamma RIIb

Thursday, March 01 | 5:00PM - 6:45PM
From Molecules to the Clinic
Room: Sea to Sky B

Speaker 3 of 3
John M. Lambert, USA
Antibody-Drug Conjugates (ADCs): The Magic Bullet Revisited

Thursday, March 01 | 6:45PM - 7:00PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Sea to Sky B


Thursday, March 01 | 7:00PM - 8:00PM
Social Hour with Lite Bites
Room: Sea to Sky C
No registration fees are used to fund alcohol served at this function.

Thursday, March 01 | 8:00PM - 11:00PM
Entertainment
Room: Sea to Sky C
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Thursday, March 01 | 8:00PM - 11:00PM
Cash Bar
Room: Sea to Sky C


Friday, March 02 | 10:24AM - 10:24AM
Departure


*Session Chair.

No content found

No content found

No content found